EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation

Katharina Hilbig, Russell Towers, Marc Schmitz, Martin Bornhäuser, Petra Lennig, Yixin Zhang iD

Molecules · 2024

DOI: 10.3390/molecules29122779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Katharina Hilbig und 5 weiteren Autor:innen. Beteiligte Einrichtung: B CUBE Center for Molecular Bioengineering, Technische Universität Dresden, Tatzberg 41, 01307 Dresden, Germany. Hauptthemen laut MEDLINE: Cyclophilin A, Cyclosporine, Proteolysis, T-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung (BMBF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophilin A (CypA), the cellular receptor of the immunosuppressant cyclosporin A (CsA), is an abundant cytosolic protein and is involved in a variety of diseases. For example, CypA supports cancer proliferation and mediates viral infections, such as the human immunodeficiency virus 1 (HIV-1). Here, we present the design of PROTAC (proteolysis targeting chimera) compounds against CypA to induce its intracellular proteolysis and to investigate their effect on immune cells. Interestingly, upon connecting to E3 ligase ligands, both peptide-based low-affinity binders and CsA-based high-affinity binders can degrade CypA at nM concentration in HeLa cells and fibroblast cells. As the immunosuppressive effect of CsA is not directly associated with the binding of CsA to CypA but the inhibition of phosphatase calcineurin by the CypA:CsA complex, we investigated whether a CsA-based PROTAC compound could induce CypA degradation without affecting the activation of immune cells. P3, the most efficient PROTAC compound discovered from this study, could deplete CypA in lymphocytes without affecting cell proliferation and cytokine production. This work demonstrates the feasibility of the PROTAC approach in depleting the abundant cellular protein CypA at low drug dosage without affecting immune cells, allowing us to investigate the potential therapeutic effects associated with the endogenous protein in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclophilin ACyclosporineProteolysisT-LymphocytesLymphocyte ActivationHumansHeLa CellsCell ProliferationImmunosuppressive AgentsProteolysis Targeting Chimera

Stichwörter der Autor:innen

cyclophilin A (CypA)cyclosporin A (CsA)protein degradationprotein–protein interactionsproteolysis targeting chimera (PROTAC)

Substanzen

Cyclophilin ACyclosporineImmunosuppressive AgentsProteolysis Targeting Chimera

Autor:innen und Institutionen

  • B CUBE Center for Molecular Bioengineering, Technische Universität Dresden, Tatzberg 41, 01307 Dresden, Germany.
  • Department of Internal Medicine I, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
  • German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), 01307 Dresden, Germany.
  • School of Cancer and Pharmaceutical Science, King's College, London WC2R 2LS, UK.
  • Cluster of Excellence Physics of Life, Technische Universität Dresden, 01307 Dresden, Germany.

ORCID-Profile: Yixin Zhang

Förderung

  • Bundesministerium für Bildung und Forschung (BMBF)

Zitieren

APA

Hilbig, K., Towers, R., Schmitz, M., Bornhäuser, M., Lennig, P., & Zhang, Y. (2024). Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation. Molecules. https://doi.org/10.3390/molecules29122779

Vancouver

Hilbig K, Towers R, Schmitz M, Bornhäuser M, Lennig P, Zhang Y. Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation. Molecules. 2024. doi:10.3390/molecules29122779

BibTeX
@article{Hilbig2024,
  author = {Hilbig, Katharina and Towers, Russell and Schmitz, Marc and Bornhäuser, Martin and Lennig, Petra and Zhang, Yixin},
  title = {Cyclosporin A-Based PROTACs Can Deplete Abundant Cellular Cyclophilin A without Suppressing T Cell Activation},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29122779}
}
Kostenlos starten →